Co-Authors
This is a "connection" page, showing publications co-authored by Giuliano Rizzardini and Maria Cossu.
Connection Strength
0.815
-
Impressive Boosting of Anti-S1/S2 Immunoglobulin G Production in Coronavirus Disease 2019 (COVID-19)-experienced Patients After the First Shot of the BNT162b2 Messenger RNA COVID-19 Vaccine. Clin Infect Dis. 2021 09 15; 73(6):e1402-e1403.
Score: 0.242
-
One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG. J Infect. 2021 08; 83(2):237-279.
Score: 0.237
-
Short-term inhibition of SARS-CoV-2 by hydrogen peroxide in persistent nasopharyngeal carriers. J Med Virol. 2021 03; 93(3):1766-1769.
Score: 0.226
-
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy. Eur J Intern Med. 2020 06; 76:36-42.
Score: 0.055
-
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status. Pharmacol Res. 2020 08; 158:104899.
Score: 0.055